Blind Versus Targeted Epidural Patch With Autologous Platelet-rich Plasma for Spontaneous Intracranial Hypotension
NCT07283536 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2026-05-11
Summary
Spontaneous intracranial hypotension (SIH) is a condition characterized by refractory orthostatic headache, mostly due to loss of cerebrospinal fluid (CSF). Epidural patch with autologous platelet-rich plasma (PRP), which contains numerous growth factors and cytokines, has been reported as a successful alternative for whole blood in dura repair. However, there is no report regarding the best approach to use: targeted epidural PRP patch (TEPP) versus blind epidural PRP patch (BEPP). Preliminary work has suggested that both targeted and blind approaches are effective when using whole blood for epidural patch. Furthermore, two-site blind approach could be considered as a viable initial treatment regardless of the identification of the leak for conventional targeted approach. In this study, the investigators aimed to investigate the non-inferiority of two-site BEPP compared with TEPP for the treatment of refractory SIH cases failing in conservative therapy.
Conditions
- Spontaneous Intracranial Hypotension
Interventions
- PROCEDURE
-
Targeted epidural PRP patch
Each patient was subjected to either magnetic resonance myelography (MRM) or/and computed tomography myelography (CTM) to detect the location of CSF leaking. PRP was prepared with the 2-stage centrifugation method and a standard epidural puncture was conducted at the definitive CSF leak locations under the guidance of CT. A predetermined volume of PRP (no more than 10 mL) was titrated slowly into the epidural space for each level. A strict bed stay for 48 h was prescribed in supine position postoperatively.
- PROCEDURE
-
Blind epidural PRP patch
PRP was prepared with the 2-stage centrifugation method and the investigators chose two separate sites for epidural access, the C7-T1 and L4-5 levels. A standard epidural puncture was conducted under the guidance of CT. A predetermined volume of PRP (no more than 10 mL) was titrated slowly into the epidural space for each level. A strict bed stay for 48 h was prescribed in supine position postoperatively.
Sponsors & Collaborators
-
Beijing Tiantan Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-20
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
More Related Trials
-
Efficacy of Percutaneous SPG Block in Aneurysmal SAH
NCT04331938 ·Status: COMPLETED ·Phase: PHASE1
-
Epidural Blood Patch on the Resolution of Postdural Puncture Headache (PDPH)
NCT00373074 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Establishment of a Predictive Model for Post-dural Puncture Headache
NCT06800859 ·Status: ENROLLING_BY_INVITATION
-
Extracorporeal Filtration of Subarachnoid Hemorrhage Via Spinal Catheter
NCT02872636 ·Status: COMPLETED ·Phase: NA
-
Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache
NCT02427009 ·Status: TERMINATED ·Phase: NA
-
Pituitary Function and Spontaneous Intracranial Hypotension
NCT02603549 ·Status: SUSPENDED
-
A Low ChloridE hyperTonic Solution for Brain Edema
NCT03204955 ·Status: COMPLETED ·Phase: PHASE1
-
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
NCT02347878 ·Status: UNKNOWN ·Phase: PHASE4
-
Sphenopalatine Ganglion Block for Headache After Concussion
NCT04650282 ·Status: TERMINATED ·Phase: PHASE2
-
Pathophysiology and Treatment of Cerebrospinal Hypotension Exploration Study
NCT06805591 ·Status: ENROLLING_BY_INVITATION
-
Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Randomized Controlled Trial
NCT07307508 ·Status: RECRUITING ·Phase: NA
-
China Research for Severe Spontaneous Intracerebral Hemorrhage(CRISIH)
NCT05975398 ·Status: RECRUITING
-
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
NCT04580238 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Prospective Controlled Treatment Trial for Post-Traumatic Headaches
NCT03007420 ·Status: TERMINATED ·Phase: PHASE3
-
Factors Associated With the Onset of Chronic Headaches in Patients Who Received a Blood Patch in Post Partum
NCT05888324 ·Status: ACTIVE_NOT_RECRUITING
-
Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache
NCT05365880 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
NCT03566602 ·Status: COMPLETED ·Phase: NA
-
Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage
NCT07116408 ·Status: RECRUITING ·Phase: PHASE4
-
Long-term Complications of Unintentional Dural Puncture During Labour Epidurals and Epidural Blood Patch.
NCT04696627 ·Status: COMPLETED
-
Study Evaluating Sphenopalatine Ganglion Block (SPGB) for Treatment of Postdural Puncture Headache (PDPH)
NCT02365909 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment
NCT03276975 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.
NCT00248807 ·Status: COMPLETED ·Phase: NA
-
Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture
NCT05116930 ·Status: RECRUITING ·Phase: PHASE2
-
Detecting Syncope by an Integrated Multisensor Patch-type Recorder
NCT05782699 ·Status: COMPLETED ·Phase: NA
-
OPtimal Timing of Thromboprophylaxis in Traumatic IntraCranial Haemorrhage (OPTTTICH Feasibility Study)
NCT01589393 ·Status: COMPLETED ·Phase: NA